vs
FLOTEK INDUSTRIES INC（FTK）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是FLOTEK INDUSTRIES INC的1.1倍（$75.5M vs $67.5M），FLOTEK INDUSTRIES INC同比增速更快（33.0% vs 27.7%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 29.3%）
Flotek Industries是一家技术驱动的多元化企业，主要开发和供应特种化学品、高性能材料及相关设备解决方案，服务全球能源、采矿和工业制造领域，助力客户提升运营效率。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
FTK vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.1倍
$67.5M
营收增速更快
FTK
高出5.3%
27.7%
两年增速更快
PBYI
近两年复合增速
29.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $67.5M | $75.5M |
| 净利润 | $3.0M | — |
| 毛利率 | 22.5% | 69.3% |
| 营业利润率 | 8.9% | 22.7% |
| 净利率 | 4.5% | — |
| 营收同比 | 33.0% | 27.7% |
| 净利润同比 | -31.7% | — |
| 每股收益（稀释后） | $0.09 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FTKPBYI
| Q4 25 | $67.5M | $75.5M | ||
| Q3 25 | $56.0M | $54.5M | ||
| Q2 25 | $58.4M | $52.4M | ||
| Q1 25 | $55.4M | $46.0M | ||
| Q4 24 | $50.8M | $59.1M | ||
| Q3 24 | $49.7M | $80.5M | ||
| Q2 24 | $46.2M | $47.1M | ||
| Q1 24 | $40.4M | $43.8M |
净利润FTKPBYI
| Q4 25 | $3.0M | — | ||
| Q3 25 | $20.4M | $8.8M | ||
| Q2 25 | $1.8M | $5.9M | ||
| Q1 25 | $5.4M | $3.0M | ||
| Q4 24 | $4.4M | — | ||
| Q3 24 | $2.5M | $20.3M | ||
| Q2 24 | $2.0M | $-4.5M | ||
| Q1 24 | $1.6M | $-4.8M |
毛利率FTKPBYI
| Q4 25 | 22.5% | 69.3% | ||
| Q3 25 | 31.7% | 77.7% | ||
| Q2 25 | 24.7% | 76.5% | ||
| Q1 25 | 22.5% | 77.1% | ||
| Q4 24 | 24.2% | 76.4% | ||
| Q3 24 | 18.3% | 63.9% | ||
| Q2 24 | 19.9% | 77.4% | ||
| Q1 24 | 21.8% | 75.5% |
营业利润率FTKPBYI
| Q4 25 | 8.9% | 22.7% | ||
| Q3 25 | 16.2% | 17.6% | ||
| Q2 25 | 4.4% | 12.7% | ||
| Q1 25 | 10.1% | 8.7% | ||
| Q4 24 | 10.1% | 22.6% | ||
| Q3 24 | 5.5% | 27.4% | ||
| Q2 24 | 4.8% | -4.6% | ||
| Q1 24 | 5.2% | -5.3% |
净利率FTKPBYI
| Q4 25 | 4.5% | — | ||
| Q3 25 | 36.3% | 16.2% | ||
| Q2 25 | 3.0% | 11.2% | ||
| Q1 25 | 9.7% | 6.5% | ||
| Q4 24 | 8.7% | — | ||
| Q3 24 | 5.1% | 25.2% | ||
| Q2 24 | 4.3% | -9.6% | ||
| Q1 24 | 3.9% | -11.0% |
每股收益（稀释后）FTKPBYI
| Q4 25 | $0.09 | $0.26 | ||
| Q3 25 | $0.53 | $0.17 | ||
| Q2 25 | $0.05 | $0.12 | ||
| Q1 25 | $0.17 | $0.06 | ||
| Q4 24 | $0.15 | $0.40 | ||
| Q3 24 | $0.08 | $0.41 | ||
| Q2 24 | $0.06 | $-0.09 | ||
| Q1 24 | $0.05 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.7M | $97.5M |
| 总债务越低越好 | $40.0M | $22.7M |
| 股东权益账面价值 | $113.1M | $130.3M |
| 总资产 | $220.0M | $216.3M |
| 负债/权益比越低杠杆越低 | 0.35× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资FTKPBYI
| Q4 25 | $5.7M | $97.5M | ||
| Q3 25 | $4.6M | $94.4M | ||
| Q2 25 | $5.0M | $96.0M | ||
| Q1 25 | $6.3M | $93.2M | ||
| Q4 24 | $4.4M | $101.0M | ||
| Q3 24 | $5.0M | $96.7M | ||
| Q2 24 | $4.8M | $96.8M | ||
| Q1 24 | $5.2M | $107.2M |
总债务FTKPBYI
| Q4 25 | $40.0M | $22.7M | ||
| Q3 25 | $40.0M | $34.0M | ||
| Q2 25 | $40.0M | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | $194.0K | $102.0M |
股东权益FTKPBYI
| Q4 25 | $113.1M | $130.3M | ||
| Q3 25 | $110.5M | $115.3M | ||
| Q2 25 | $71.8M | $104.7M | ||
| Q1 25 | $119.7M | $97.1M | ||
| Q4 24 | $113.9M | $92.1M | ||
| Q3 24 | $109.0M | $71.1M | ||
| Q2 24 | $106.2M | $48.5M | ||
| Q1 24 | $103.9M | $51.0M |
总资产FTKPBYI
| Q4 25 | $220.0M | $216.3M | ||
| Q3 25 | $212.7M | $202.9M | ||
| Q2 25 | $172.2M | $194.9M | ||
| Q1 25 | $170.2M | $196.2M | ||
| Q4 24 | $170.8M | $213.3M | ||
| Q3 24 | $160.6M | $220.7M | ||
| Q2 24 | $156.0M | $205.0M | ||
| Q1 24 | $155.8M | $214.1M |
负债/权益比FTKPBYI
| Q4 25 | 0.35× | 0.17× | ||
| Q3 25 | 0.36× | 0.30× | ||
| Q2 25 | 0.56× | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | 0.00× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $6.2M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | 2.07× | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流FTKPBYI
| Q4 25 | $6.2M | $14.4M | ||
| Q3 25 | $-1.9M | $9.7M | ||
| Q2 25 | $-4.5M | $14.1M | ||
| Q1 25 | $7.3M | $3.6M | ||
| Q4 24 | $-2.6M | $15.6M | ||
| Q3 24 | $5.1M | $11.0M | ||
| Q2 24 | $-3.1M | $1.0M | ||
| Q1 24 | $3.9M | $11.2M |
自由现金流FTKPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率FTKPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度FTKPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率FTKPBYI
| Q4 25 | 2.07× | — | ||
| Q3 25 | -0.09× | 1.10× | ||
| Q2 25 | -2.54× | 2.41× | ||
| Q1 25 | 1.36× | 1.21× | ||
| Q4 24 | -0.58× | — | ||
| Q3 24 | 2.01× | 0.54× | ||
| Q2 24 | -1.55× | — | ||
| Q1 24 | 2.49× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FTK
| Related Party | $49.6M | 74% |
| Nonrelated Party | $17.9M | 26% |
PBYI
暂无分部数据
